Smith Bryan E. 4
4 · Eledon Pharmaceuticals, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Smith Bryan E.
General Counsel, Corporate Sec
Transactions
- Award
Stock Option (right to buy)
2024-06-13+241,650→ 241,650 totalExercise: $2.30Exp: 2033-05-01→ Common Stock (241,650 underlying)
Footnotes (1)
- [F1]This transaction represents the attainment of the performance conditions applicable to an option award subject to both performance-based and time-based vesting criteria granted to the reporting person on May 1, 2023. The option was determined to satisfy the performance-based vesting criteria with respect to 241,650 shares of underlying Common Stock on June 13, 2024 and time-based vesting criteria with respect to 60,413 shares of underlying Common Stock on May 1, 2024. The option will satisfy the time-based vesting criteria with respect to the 181,237 remaining shares of Common Stock underlying the option in substantially equal quarterly installments over a three-year period ending May 1, 2027.